Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
84
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

190
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
190
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
125
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collateral harms following opioid prescribing standard.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2025
Same author

Basic Training in Palliative Medicine for Internal Medicine Residents: Pilot Testing of a Canadian Model in Switzerland.

Palliative medicine reports·2024
Same author

Response to Medical Assistance in Dying, Palliative Care, Safety, and Structural Vulnerability.

Journal of palliative medicine·2023
Same author

Response to Downar J et al., Medical Assistance in Dying and Palliative Care: Shared Trajectories (DOI: 10.1089/jpm.2023.0209).

Journal of palliative medicine·2023
Same author

Nicotine withdrawal as an unusual cause of terminal delirium.

Canadian family physician Medecin de famille canadien·2022
Same author

Electrophysiological evidence of sustained attention to music among conscious participants and unresponsive hospice patients at the end of life.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2022

Related Experiment Video

Updated: Jun 21, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K

Managing Pruritus in Advanced Chronic Disease.

Ebru Kaya1,2, Gord McDonald3,4, Romayne Gallagher5

  • 1Department of Supportive Care, Toronto General Hospital, University Health Network, Toronto, Canada.

Journal of Palliative Medicine
|July 9, 2024
PubMed
Summary

Pruritus, or itch, is common in chronic disease but undertreated. This review examines itch mechanisms and therapies for non-cancer organ failure, highlighting limitations in current research.

Keywords:
chronic diseaseitchnoncancerpruritus

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

279
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K

Related Experiment Videos

Last Updated: Jun 21, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

279
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K

Area of Science:

  • Nephrology
  • Dermatology
  • Pharmacology

Background:

  • Pruritus significantly impacts patients with chronic diseases, yet effective treatments are lacking.
  • Current therapies like antihistamines are often ineffective for systemic itch.
  • Hydroxyzine, a common treatment for kidney failure-related pruritus, is becoming unavailable.

Purpose of the Study:

  • To review the mechanisms of itch in advanced non-cancer organ failure.
  • To discuss current and potential therapies for systemic pruritus in this population.
  • To address the gap in treatment options due to the discontinuation of hydroxyzine.

Main Methods:

  • Systematic review of existing literature on pruritus in chronic non-cancer diseases.
  • Analysis of pathogenesis and treatment strategies for systemic itch.
  • Focus on studies related to advanced organ failure.

Main Results:

  • Antihistamines show limited efficacy in treating systemic pruritus.
  • Hydroxyzine is a frequently used but potentially unavailable treatment for uremic pruritus.
  • Literature on itch in chronic non-cancer diseases is often based on small cohort studies.

Conclusions:

  • There is a critical need for improved understanding and treatment of systemic pruritus in chronic organ failure.
  • The unavailability of hydroxyzine necessitates exploration of alternative therapeutic approaches.
  • Further research with larger studies is required to establish effective treatments for chronic disease-related itch.